US Shifts HIV, Malaria Aid, Risking Shortages

The US is revamping its medical supply distribution for HIV and malaria in developing nations, terminating a key program managed by Chemonics. This program, active since 2016, delivered over $5 billion worth of drugs and bed nets to 90 countries, primarily in sub-Saharan Africa and Asia. The Trump administration briefly halted aid distribution at the start of his presidency, causing millions of supplies to be stranded. Although supplies resumed, the dismantling of USAID and budget cuts have led to a shift towards direct deals with countries instead of contractors. This rapid transition may result in medicine shortages and negatively impact lives, particularly following last years gaps in childrens malaria drugs and HIV prevention. An internal email was sent to US staff in 17 African countries and Haiti, instructing them to cease operations by May 30th, despite the contracts official end date being September 30th. The State Department views the previous system as inefficient and wasteful, favoring bilateral agreements, with 28 signed so far and more funding pledged to countries like Kenya and Uganda. However, details remain unclear due to ongoing legal disputes and delays, causing aid professionals to closely monitor for potential future disruptions.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
[email protected]

This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].

View sources & latest updates:
https://sources.thednn.ai/56da914ae6ab404b